↓ Skip to main content

Carvedilol for Children and Adolescents With Heart Failure: A Randomized Controlled Trial

Overview of attention for article published in JAMA: Journal of the American Medical Association, September 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Citations

dimensions_citation
469 Dimensions

Readers on

mendeley
124 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Carvedilol for Children and Adolescents With Heart Failure: A Randomized Controlled Trial
Published in
JAMA: Journal of the American Medical Association, September 2007
DOI 10.1001/jama.298.10.1171
Pubmed ID
Authors

Robert E. Shaddy, Mark M. Boucek, Daphne T. Hsu, Robert J. Boucek, Charles E. Canter, Lynn Mahony, Robert D. Ross, Elfriede Pahl, Elizabeth D. Blume, Debra A. Dodd, David N. Rosenthal, Jeri Burr, Bernie LaSalle, Richard Holubkov, Mary Ann Lukas, Lloyd Y. Tani, For the Pediatric Carvedilol Study Group

Abstract

Although beta-blockers improve symptoms and survival in adults with heart failure, little is known about these medications in children and adolescents.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 <1%
Netherlands 1 <1%
United Kingdom 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 119 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 16%
Student > Bachelor 20 16%
Other 12 10%
Student > Ph. D. Student 10 8%
Professor 8 6%
Other 33 27%
Unknown 21 17%
Readers by discipline Count As %
Medicine and Dentistry 73 59%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Biochemistry, Genetics and Molecular Biology 5 4%
Agricultural and Biological Sciences 4 3%
Psychology 2 2%
Other 8 6%
Unknown 26 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2018.
All research outputs
#2,089,197
of 25,374,917 outputs
Outputs from JAMA: Journal of the American Medical Association
#12,701
of 36,426 outputs
Outputs of similar age
#4,428
of 82,467 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#35
of 106 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,426 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.5. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 82,467 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 106 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.